We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Agfa to Acquire Long-Time Partner Mitra

By HospiMedica staff writers
Posted on 10 Oct 2001
In a move to solidify its position in health-care informatics, Agfa-Gevaert N.V. (Mortsel, Belgium) has agreed to acquire Mitra Inc. (Waterloo, Canada), a long-time technology partner that has played an integral role in the development and success of Agfa's Impax PACS solutions. The terms of the acquisition were not disclosed.

Mitra is a leading developer of imaging and information management systems, with installations in more than 35 countries. The company says its technology interacts with every major hospital information system (HIS)/radiology information system (RIS) in the world. Its range of technologies facilitates all steps in the clinical process, from ordering to diagnostic procedures and interpretation, to results distribution and integration of the electronic patient record. Mitra will be managed as a separate business unit. The company structure, management team, and all employees will be retained.

"Mitra provides a powerful core of software expertise and technological innovation, which will form the core of our Healthcare Informatics business,” said John Glass, general manager, Agfa Healthcare. "They will continue to lead us, and their other OEM partners, in the development of enterprise integration software.”




Related Links:
Agfa
Mitra
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
New
LED Surgical Lamp
ACEMST35/57

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more